Paclitaxel CAS 33069-62-4 Anticancer GMP onye na-emepụta paclitaxel kwadoro

Nkọwa dị mkpirikpi:

Paclitaxel bụ metabolite nke abụọ ekepụrụ ma dị ọcha site na ogbugbo nke gymnosperm Taxus tract cancer.A na-eji alaka Yew na akwụkwọ agwọ ọrịa leukemia, nephritis, ọrịa shuga, na ọrịa akụrụ polycystic.Paclitaxel bụ ọgwụ mgbochi ọrịa cancer kachasị ewu ewu n'afọ ndị na-adịbeghị anya ma a na-ewere ya dị ka otu n'ime ọgwụ mgbochi ọrịa cancer kachasị dị irè n'ime afọ 20 na-esote.


Nkọwa ngwaahịa

Mkpado ngwaahịa

Ozi ngwaahịa

Aha:Paclitaxel eke

Nọmba CAS:33069-62-4

Usoro kemịkalụ:C47H51NO14

Nkọwapụta:99%-102%

Agba:ọcha ma ọ bụ ihe fọrọ nke nta ka ọ bụrụ ntụ ntụ ọcha

Isi mmalite:Taxus yunnanensis, Taxus chinensis

Ụdị:API

Hande mmepụta okirikiri & ikike

Usoro mmepụta:Ụbọchị 45

Ike mmepụta Hande:500kg / afọ

Akụkọ ihe mere eme nke Hande GMP

1. Na 1996, e guzobere usoro mma ma nweta DMF.

2. Na 2004, FDA on-site nnyocha nwetara CGMP akwụkwọ.

3. Na 2009, a na-enweta paclitaxel semi-synthetic DMF na paclitaxel CEP eke.

4. N'afọ 2011, e nwetara paclitaxel CEP semi-synthetic.

5. Na 2012, gafere nyocha TGA na saịtị, nweta asambodo GMP, wee gafee nyocha nke saịtị FDA.

6. Na 2013, gafere saịtị CGMP.

7. N'afọ 2015, e debanyere aha India na aha Japan.

Ọrụ anyị

1.Ngwaahịa:Nye elu-edu, elu-ọcha osisi wepụ, ọgwụ akụrụngwa, na ọgwụ intermediates.

2.Ọrụ nka:Mwepụta ahaziri iche nwere nkọwa pụrụ iche dị ka ihe ndị ahịa chọrọ.

Ụlọ ọrụ Hande

Bụrụ onye na-ebubata akụrụngwa na ụlọ ọrụ na-eguzosi ike n'ezi ihe!

Nnọọ ịkpọtụrụ m site na izipu email namarketing@handebio.com


  • Nke gara aga:
  • Osote: